Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083945384> ?p ?o ?g. }
- W2083945384 endingPage "266" @default.
- W2083945384 startingPage "261" @default.
- W2083945384 abstract "SUMMARY 1. Previous studies have suggested the involvement of arginine vasopressin (AVP) and inflammation in the development of cerebral vasospasm after subarachnoid haemorrhage (SAH). The aim of the present study was to clarify the role of AVP in the arterial narrowing following cerebral haemorrhage by examining the effect of SR 49059 (a V 1 receptor antagonist) on the diameter of rat basilar artery exposed to SAH. The effect of the 5‐lipoxygenase inhibitor ZM 230487 on AVP‐induced contraction of rat basilar arteries was also investigated. 2. After 1 h and 2 days from SAH induction, brains were removed and pictures of the basilar arteries were taken. The external diameter of the basilar artery was measured in the presence and absence of SR 49059 (1 mg/kg, i.v.). For in vitro experiments, the basilar arteries isolated from control and SAH rats (at 1 h and at 2 days from SAH induction) were cut into spiral preparations and the AVP (0.3 nmol/L)‐induced contraction in the presence of ZM 230487 was investigated. Each group analysed (i.e. control, SAH 1 h and SAH 2 days) consisted of eight rats. 3. The diameter of rat basilar arteries decreased by 43 and 25% at 1 h and 2 days from SAH induction, respectively, compared with control. The administration of SR 49059 significantly reduced cerebral vasospasm. After SAH induction, the diameter of the basilar artery in SR 49059‐treated groups decreased by only 22% (at 1 h) and by 3% (at 2 days) compared with the control group ( P < 0.01). In basilar arterial strips, ZM 230487 attenuated the vasopressin‐induced contraction in both control and SAH groups. However, SAH groups showed a significant resistance of the AVP‐induced contraction in the presence of ZM 230487 compared with control ( P < 0.05). 4. The results suggest that the cerebral vasospasm in SAH rats is due, at least in part, to endogenous AVP and may involve an increase in the activity of 5‐lipoxygenase. SR 49059 may represent a potential therapeutic strategy for the treatment of cerebral vasospasm." @default.
- W2083945384 created "2016-06-24" @default.
- W2083945384 creator A5022419331 @default.
- W2083945384 creator A5033622393 @default.
- W2083945384 creator A5053147428 @default.
- W2083945384 creator A5059005916 @default.
- W2083945384 creator A5081202199 @default.
- W2083945384 creator A5091775496 @default.
- W2083945384 date "2004-03-26" @default.
- W2083945384 modified "2023-10-15" @default.
- W2083945384 title "PARTICIPATION OF VASOPRESSIN IN THE DEVELOPMENT OF CEREBRAL VASOSPASM IN A RAT MODEL OF SUBARACHNOID HAEMORRHAGE" @default.
- W2083945384 cites W1482299255 @default.
- W2083945384 cites W1969634271 @default.
- W2083945384 cites W1972583947 @default.
- W2083945384 cites W1976040649 @default.
- W2083945384 cites W1985332320 @default.
- W2083945384 cites W1986321763 @default.
- W2083945384 cites W1992516038 @default.
- W2083945384 cites W1999187765 @default.
- W2083945384 cites W2001997798 @default.
- W2083945384 cites W2004700146 @default.
- W2083945384 cites W2005021150 @default.
- W2083945384 cites W2013145109 @default.
- W2083945384 cites W2013531101 @default.
- W2083945384 cites W2022562192 @default.
- W2083945384 cites W2025700770 @default.
- W2083945384 cites W2027467507 @default.
- W2083945384 cites W2040470785 @default.
- W2083945384 cites W2050388980 @default.
- W2083945384 cites W2066375077 @default.
- W2083945384 cites W2068190426 @default.
- W2083945384 cites W2082657386 @default.
- W2083945384 cites W2084760262 @default.
- W2083945384 cites W2087941770 @default.
- W2083945384 cites W2088419308 @default.
- W2083945384 cites W2093141364 @default.
- W2083945384 cites W2102454133 @default.
- W2083945384 cites W2107865846 @default.
- W2083945384 cites W2125645759 @default.
- W2083945384 cites W2129132447 @default.
- W2083945384 cites W2134592756 @default.
- W2083945384 cites W2138684097 @default.
- W2083945384 cites W2147986625 @default.
- W2083945384 cites W2148406674 @default.
- W2083945384 cites W2149180520 @default.
- W2083945384 cites W2166479551 @default.
- W2083945384 cites W2442648597 @default.
- W2083945384 cites W2494896681 @default.
- W2083945384 doi "https://doi.org/10.1111/j.1440-1681.2004.03986.x" @default.
- W2083945384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15053824" @default.
- W2083945384 hasPublicationYear "2004" @default.
- W2083945384 type Work @default.
- W2083945384 sameAs 2083945384 @default.
- W2083945384 citedByCount "42" @default.
- W2083945384 countsByYear W20839453842012 @default.
- W2083945384 countsByYear W20839453842013 @default.
- W2083945384 countsByYear W20839453842014 @default.
- W2083945384 countsByYear W20839453842016 @default.
- W2083945384 countsByYear W20839453842019 @default.
- W2083945384 countsByYear W20839453842022 @default.
- W2083945384 crossrefType "journal-article" @default.
- W2083945384 hasAuthorship W2083945384A5022419331 @default.
- W2083945384 hasAuthorship W2083945384A5033622393 @default.
- W2083945384 hasAuthorship W2083945384A5053147428 @default.
- W2083945384 hasAuthorship W2083945384A5059005916 @default.
- W2083945384 hasAuthorship W2083945384A5081202199 @default.
- W2083945384 hasAuthorship W2083945384A5091775496 @default.
- W2083945384 hasConcept C126322002 @default.
- W2083945384 hasConcept C134018914 @default.
- W2083945384 hasConcept C163415756 @default.
- W2083945384 hasConcept C171614378 @default.
- W2083945384 hasConcept C2776370428 @default.
- W2083945384 hasConcept C2776820941 @default.
- W2083945384 hasConcept C2777736543 @default.
- W2083945384 hasConcept C2778506911 @default.
- W2083945384 hasConcept C2781012200 @default.
- W2083945384 hasConcept C42219234 @default.
- W2083945384 hasConcept C71924100 @default.
- W2083945384 hasConceptScore W2083945384C126322002 @default.
- W2083945384 hasConceptScore W2083945384C134018914 @default.
- W2083945384 hasConceptScore W2083945384C163415756 @default.
- W2083945384 hasConceptScore W2083945384C171614378 @default.
- W2083945384 hasConceptScore W2083945384C2776370428 @default.
- W2083945384 hasConceptScore W2083945384C2776820941 @default.
- W2083945384 hasConceptScore W2083945384C2777736543 @default.
- W2083945384 hasConceptScore W2083945384C2778506911 @default.
- W2083945384 hasConceptScore W2083945384C2781012200 @default.
- W2083945384 hasConceptScore W2083945384C42219234 @default.
- W2083945384 hasConceptScore W2083945384C71924100 @default.
- W2083945384 hasIssue "4" @default.
- W2083945384 hasLocation W20839453841 @default.
- W2083945384 hasLocation W20839453842 @default.
- W2083945384 hasOpenAccess W2083945384 @default.
- W2083945384 hasPrimaryLocation W20839453841 @default.
- W2083945384 hasRelatedWork W1997925169 @default.
- W2083945384 hasRelatedWork W2016261780 @default.
- W2083945384 hasRelatedWork W2018028464 @default.
- W2083945384 hasRelatedWork W2018598934 @default.